Answers are grounded in this paper and cite their sources.
This study aimed to investigate the protective effects of quercetin against cyclophosphamide (CP)-induced ovarian toxicity in mice. Twenty-four healthy mice were allocated into four groups: control (C), sham (S), CP, and CP+quercetin (CPQ) (n = 6/group). The S group received oral dimethyl sulfoxide (DMSO; 0.5 mL/day) for 14 days. The CP and CPQ groups received two intraperitoneal injections of CP (200 mg/kg) at one-week intervals. Additionally, the CPQ group received oral quercetin (50 mg/kg/day) dissolved in DMSO for 14 days. Serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), ovarian follicle counts, and Bax and caspase-3 immunoexpression were evaluated. TAS levels were significantly lower, whereas TOS and OSI levels were higher in the CP group than in the other groups. CP treatment significantly reduced primordial, primary, secondary, and antral follicle counts while increasing atretic follicles. Quercetin supplementation significantly increased primordial follicle numbers compared with the CP group (p = 0.011). Furthermore, Bax and caspase-3 immunoexpression levels were significantly elevated following CP administration, whereas quercetin reduced Bax expression (p = 0.012). In conclusion, cyclophosphamide led to pathological consequences in oxidative status and the ovary. However, treatment with quercetin had positive effects on oxidative stress status and ovarian histodynamics in mice with cyclophosphamide-induced ovarian toxicity.
No takes yet. Share an insight, caveat, or question.
Kurt et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: